Target Healthcare REIT PLC Notice of Full Year Results

RNS Number : 9409D

Target Healthcare REIT PLC

12 September 2024

 

12 September 2024

Target Healthcare REIT plc and its subsidiaries

("Target Healthcare" or "the Group")

 

Notice of Full Year Results

Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, will announce its full year results for the twelve months ended 30 June 2024 on Tuesday, 17 September 2024.

There will be a live webcast for analysts and investors at 08.15 BST on the day of the results.

For further information or to register your attendance, please get in touch with FTI Consulting at:
[e-mail].

Enquiries:

 

Target Fund Managers: Kenneth MacKenzie Gordon Bland	Tel: [phone]
FTI Consulting: Dido Laurimore Richard Gotla	Tel: [phone] [e-mail]
Talia Shirion

 

Notes:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 30 June 2024 comprised 94 assets let to 34 tenants with a total value of £908.5 million.

The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.

LEI: 213800RXPY9WULUSBC04

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NORDLLBFZKLXBBB